Prevention and treatment of infections in patients with cirrhosis

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 1, 2007, Pages 77-93

  Ghassemi, Sahar ^b   Garcia Tsao, Guadalupe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

bacterial infection; bacterial translocation; cirrhosis; spontaneous bacterial peritonitis

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; ENDOTOXIN; HETASTARCH; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN;

ACUTE KIDNEY FAILURE; ANTIBIOTIC RESISTANCE; ARTICLE; ASCITES FLUID ANALYSIS; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG DOSAGE FORM COMPARISON; ESCHERICHIA COLI; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MOTILITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INDIVIDUALIZATION; INTESTINE FLORA; INTESTINE MUCOSA; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; MESENTERY LYMPH NODE; MONOTHERAPY; MORBIDITY; MORTALITY; MUCOSAL IMMUNITY; PARACENTESIS; PATHOGENESIS; PATIENT CARE; PERITONEAL FLUID; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; LIVER CIRRHOSIS; PERITONITIS; QUINOLONES;

EID: 33846128112     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.07.004     Document Type: Article

References (82)

1. Fernandez J., Navasa M., Gomez J., et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35 (2002) 140-148
2. Borzio M., Salerno F., Piantoni L., et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Digest Liver Dis 33 (2001) 41-48
3. Bernard B., Grange J.D., Khac E.N., et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29 (1999) 1655-1661
4. Garcia-Tsao G., and Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 18 (2004) 353-372
5. Garcia-Tsao G. Spontaneous bacterial peritonitis: a historical perspective. J Hepatol 41 (2004) 522-527
6. Ricart E., Soriano G., Novella M., et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 32 (2000) 596-602
7. Terg R., Cobas S., Fassio E., et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol 33 (2000) 564-569
8. Berg R.D., and Garlington A.W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph noddes and other organs in a gnotobiotic mouse model. Infect Immun 23 (1979) 403-411
9. Steffen E.K., Berg R.D., and Deitch E.A. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 157 (1988) 1032-1038
10. Wells C.L., Maddaus M.A., Reynolds C.M., et al. Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun 55 (1987) 2689-2694
11. Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastro Clin North Am 21 (1992) 257-275
12. Garcia-Tsao G., Albillos A., Barden G.E., et al. Bacterial translocation in acute and chronic portal hypertension. Hepatology 17 (1993) 1081-1085
13. Garcia-Tsao G., Lee F.Y., Barden G.E., et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108 (1995) 1835-1841
14. Rimola A., Soto R., Bory F., et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4 (1984) 53-58
15. Bolognesi M., Merkel C., Bianco S., et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 19 (1994) 628-634
16. Gomez F., Ruiz P., and Schreiber A.D. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 331 (1994) 1122-1128
17. Mal F., Huu T.P., Bendahou M., et al. Chemoattractant and opsonic activity in ascitic fluid. A study in 47 patients with cirrhosis or malignant peritonitis. J Hepatol 12 (1991) 45-49
18. Homann C., Varming K., Hogasen K., et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 40 (1997) 544-549
19. Runyon B.A., Morrissey R.L., Hoefs J.C., et al. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology 5 (1985) 634-637
20. Guarner C., Sola R., Soriano G., et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 117 (1999) 414-419
21. Bobadilla M., Sifuentes J., and Garcia-Tsao G. Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis. J Clin Microbiol 27 (1989) 2145-2147
22. Rimola A., Garcia-Tsao G., Navasa M., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 32 (2000) 142-153
23. Runyon B.A., and Hoefs J.C. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 4 (1984) 447-450
24. Runyon B.A., and Hoefs J.C. Spontaneous vs secondary bacterial peritonitis. Differentiation by response of ascitic fluid neutrophil count to antimicrobial therapy. Arch Intern Med 146 (1986) 1563-1565
25. Garcia-Tsao G., Conn H.O., and Lerner E. The diagnosis of bacterial peritonitis: comparison of pH, lactate concentration and leukocyte count. Hepatology 5 (1985) 91-96
26. Vanbiervliet G., Rakotoarisoa C., Filippi J., et al. Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 14 (2002) 1257-1260
27. Castellote J., Lopez C., Gornals J., et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology 37 (2003) 893-896
28. Butani R.C., Shaffer R.T., Szyjkowski R.D., et al. Rapid diagnosis of infected ascitic fluid using leukocyte esterase dipstick testing. Am J Gastroenterol 99 (2004) 532-537
29. Thevenot T., Cadranel J.F., Nguyen-Khac E., et al. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips. Eur J Gastroenterol Hepatol 16 (2004) 579-583
30. Sapey T., Kabissa D., Fort E., et al. Instant diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips: Nephur-Test vs. MultistixSG. Liver Int 25 (2005) 343-348
31. Kim D.Y., Kim J.H., Chon C.Y., et al. Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int 25 (2005) 1197-1201
32. Castellote J., Lopez C., Gornals J., et al. Use of reagent strips for the rapid diagnosis of spontaneous bacterial empyema. J Clin Gastroenterol 39 (2005) 278-281
33. Campillo B., Richardet J.P., and Dupeyron C. Diagnostic value of two reagent strips (Multistix 8 SG and Combur 2 LN) in cirrhotic patients with spontaneous bacterial peritonitis and symptomatic bacterascites. Gastroenterol Clin Biol 30 (2006) 446-452
34. Evans L.T., Kim W.R., Poterucha J.J., et al. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 37 (2003) 897-901
35. Romney R., Mathurin P., Ganne-Carrie N., et al. Usefulness of routine analysis of ascitic fluid at the time of therapeutic paracentesis in asymptomatic outpatients. Results of a multicenter prospective study. Gastroenterol Clin Biol 29 (2005) 275-279
36. Jeffries M.A., Stern M.A., Gunaratnam N.T., et al. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis. Am J Gastroenterol 94 (1999) 2972-2976
37. Tito L., Rimola A., Gines P., et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 8 (1988) 27-31
38. Felisart J., Rimola A., Arroyo V., et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 5 (1985) 457-462
39. Runyon B.A., McHutchison J.G., Antillon M.R., et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology 100 (1991) 1737-1742
40. Rimola A., Salmeron J.M., Clemente G., et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 21 (1995) 674-679
41. Mercader J., Gomez J., Ruiz J., et al. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy 35 (1989) 23-26
42. Gomez-Jimenez J., Ribera E., Gasser I., et al. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother 37 (1993) 1587-1592
43. Mesquita M.A., Balbino E.P.S., Abuquerque R.S., et al. Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis. Hepato-Gastroenterology 44 (1997) 1276-1280
44. Garcia-Tsao G. Spontaneous bacterial peritonitis. In: Weinstein W.M., Hawkey C.J., and Bosch J. (Eds). Clinical gastroenterology and hepatology (2005), Elsevier, Spain 723-728
45. Garcia-Tsao G. Further evidence against the use of aminoglycosides in cirrhotic patients. Gastroenterology 114 (1998) 612-613
46. Hampel H., Bynum G.D., Zamora E., et al. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 96 (2001) 2206-2210
47. Ariza J., Xiol X., Esteve M., et al. Aztreonam vs cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. Hepatology 14 (1991) 91-98
48. Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol 42 supplement (2005) S85-S92
49. Navasa M., Follo A., Llovet J.M., et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 111 (1996) 1011-1017
50. Garcia-Tsao G. Treatment of spontaneous bacterial peritonitis with oral ofloxacin: inpatient or outpatient therapy?. Gastroenterology 111 (1996) 1147-1150
51. Angeli P., Guarda S., Fasolato S., et al. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther 23 (2006) 75-84
52. Ortiz J., Vila M.C., Soriano G., et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 29 (1999) 1064-1069
53. Toledo C., Salmeron J.M., Rimola A., et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 17 (1993) 251-257
54. Llovet J.M., Planas R., Morillas R., et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 88 (1993) 388-392
55. Follo A., Llovet J.M., Navasa M., et al. Renal impairment following spontaneous bacterial peritonitis in cirrhosis. Incidence, clinical course, predictive factors and prognosis. Hepatology 20 (1994) 1495-1501
56. Thuluvath P.J., Morss S., and Thompson R. Spontaneous bacterial peritonitis - In-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 96 (2001) 1232-1236
57. Campillo B., Richardet J.P., Kheo T., et al. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 35 (2002) 1-10
58. Soylu A.R., Dokmeci G., Tezel A., et al. Predictors of short-term outcome of spontaneous bacterial peritonitis in Turkish cirrhotic patients. J Gastroenterol Hepatol 20 (2005) 657-660
59. D'Amico G., Garcia-Tsao G., and Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies. J Hepatol 44 (2006) 217-231
60. Navasa M., Follo A., Filella X., et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27 (1998) 1227-1232
61. Quinlan G.J., Martin G.S., and Evans T.W. Albumin: biochemical properties and therapeutic potential. Hepatology 41 (2005) 1211-1219
62. Chuang V.T., Kragh-Hansen U., and Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 19 (2002) 569-577
63. Fernandez J., Navasa M., Garcia-Pagan J.C., et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol 41 (2004) 384-390
64. Sort P., Navasa M., Arroyo V., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341 (1999) 403-409
65. Fernandez J., Monteagudo J., Bargallo X., et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 42 (2005) 627-634
66. Wong F. Volume expanders for spontaneous bacterial peritonitis: Are we comparing oranges with oranges?. Hepatology 42 (2005) 533-535
67. Gines P., Rimola A., Planas R., et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12 (1990) 716-724
68. Inadomi J., and Sonnenberg A. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology 113 (1997) 1289-1294
69. Younossi Z.M., McHutchison J.G., and Ganiats T.G. An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis. J Hepatol 27 (1997) 295-298
70. Bauer T.M., Follo A., Navasa M., et al. Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence. Dig Dis Sci 47 (2002) 1356-1361
71. Terg R., Llano K., Cobas S.M., et al. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis - results of short- and long-term administration with daily and weekly dosages. J Hepatol 29 (1998) 437-442
72. Rimola A., Bory F., Teres J., et al. Oral, non-absorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 5 (1985) 463-467
73. Soriano G., Guarner C., Tomas A., et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 103 (1992) 1267-1272
74. Pauwels A., Mostefa-Kara N., Debenes B., et al. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 24 (1996) 802-806
75. Blaise M., Pateron D., Trinchet J.C., et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 20 (1994) 34-38
76. Hsieh W.J., Lin H.C., Hwang S.J., et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 93 (1998) 962-966
77. Llach J., Rimola A., Navasa M., et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 16 (1992) 724-727
78. Rolachon A., Cordier L., Bacq Y., et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis. Results of a prospective controlled trial. Hepatology 22 (1995) 1171-1174
79. Singh N., Gayowski T., Yu V.L., et al. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 122 (1995) 595-598
80. Novella M., Sola R., Soriano G., et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 25 (1997) 532-536
81. Grange J.D., Roulot D., Pelletier G., et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites - a double-blind randomized trial. J Hepatol 29 (1998) 430-436
82. Navasa M., Fernandez J., Montoliu S., et al. Randomized, double-blind, placebo-controlled trial evaluating norfloxacin in the primary prophylaxis of spontaneous bacterial peritonitis in cirrhotics with renal impairment, hyponatremia or severe liver failure. J Hepatol 44 supplement 2 (2006) S51 [abstract]